A Toxic Tau-PFKFB3 Circuit Reduces F2,6BP Levels and Drives Neurodegeneration
Santi M Mandal, Anirban Chakraborty, Shandy Shahabi, Mikita Mankevich, Adrián Povo‐Retana, Tapan Biswas, Sergio Sánchez‐García, Sravan Gopalkrishnashetty Sreenivasmurthy, Lucia Zhou Yang, Joseph R. Herdy, Jérôme Mertens, Fred H. Gage, Johannes C. M. Schlachetzki, Balaji Krishnan, Lisardo Boscá, , Gourisankar Ghosh
This paper identifies the PFKFB3-F2,6BP metabolic axis as a key driver of Alzheimer's disease by linking metabolic dysregulation to genomic stability and Tau proteostasis, showing that F2,6BP supplementation rescues AD phenotypes across multiple models.
bioRxiv · May 31, 2026 · PreprintNeuroscience